On February 4, 2026, Insect Shield LLC and the estate of its co-founder Richard Lane agreed to pay $1.4 million to settle allegations they violated the False Claims Act. The False Claims Act is the primary law used to combat fraud involving public funds in the United States. The settlement resolves the allegations without the defendants’ liability and ends a lengthy federal investigation.
The dispute centers on Insect Shield’s contracts with the Department of Defense (DOD) to manufacture military uniforms treated with permethrin, an insecticide designed to protect soldiers from insects.
The government claimed that from 2015 to 2021, the company and its CEO failed to meet the contract’s quality-testing requirements. Specifically, the government alleged: “Insect Shield and Lane failed to follow the permethrin testing requirements by inappropriately combining results from different rounds of testing, re-labeling test samples to hide the true origin of the samples, performing re-tests of uniforms in excess of what the contract permitted, and concealing failing test results.”
This case was initiated by a whistleblower who filed a qui tam lawsuit on behalf of the United States under the FCA. These provisions allow private citizens and private parties to file lawsuits on behalf of the government to report fraud. Qui tam whistleblowers are eligible to receive between 15 and 30% of the government’s recovery. In return for her contribution, the whistleblower will receive $315,000.
...PORTLAND, Ore. - Two men face federal charges for allegedly defrauding Medicare, the Department of Health and Human Services, the Veterans Health Administration and private insurance companies out...